A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cells

Cancer Research

Volumn 68, Issue 22, 2008, Pages 9488-9496

  Carbone, Michele ^a   Pannuti, Antonio ^a   Zhang, Lei ^a   Testa, Joseph R ^b   Bocchetta, Maurizio ^c  

^a UNIVERSITY OF HAWAII   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; COMPLEMENTARY RNA; DOUBLE STRANDED RNA;

ARTICLE; CELL IMMORTALIZATION; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MESOTHELIUM CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA DEGRADATION; SIMIAN VIRUS 40; VIRUS CARCINOGENESIS; VIRUS ONCOGENE;

ANTIGENS, POLYOMAVIRUS TRANSFORMING; BLOTTING, NORTHERN; CAPSID PROTEINS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; ENDOTHELIAL CELLS; GENE SILENCING; HUMANS; PROMOTER REGIONS, GENETIC; RNA, ANTISENSE; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SIMIAN VIRUS 40; VIRUS INTEGRATION;

EID: 56449107811     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2332     Document Type: Article

References (48)

1. Butel JS, Lednicky JA. Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst 1999;91:119-34.
2. Testa JR, Giordano A. SV40 and cell cycle perturbations in malignant mesothelioma. Semin Cancer Biol 2001;11:31-8.
3. Gordon-Shaag A, Ben-Nun-Shaul O, Roitman V, Yosef Y, Oppenheim A. Cellular transcription factor Sp1 recruits simian virus 40 capsid proteins to the viral packaging signal, ses. J Virol 2002;76:5915-24.
4. O'Neill FJ, Carney H, Hu Y. Host range analysis of simian virus 40, BK virus and chimaeric SV40/BKV: relative expression of large T-antigen and Vp1 in infected and transformed cells. Dev Biol Stand 1998;94:191-205.
5. Ozer HL, Banga SS, Dasgupta T, et al. SV40-mediated immortalization of human fibroblasts. Exp Gerontol 1996;31:303-10.
6. Gazdar AF, Butel JS, Carbone M. SV40 and human tumours: myth, association or causality? Nat Rev Cancer 2002;2:957-64.
7. Ali SK, DeCaprio JA. Cellular transformation by SV40 large T antigen: interaction with host proteins. Sem Cancer Biol 2001;11:15-21.
8. Bocchetta M, Eliasz S, DeMarco MA, Rudzinski J, Zhang L, Carbone M. The SV40 large T Antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth. Cancer Res 2008;68:1022-9.
9. Kroczynska B, Cutrone R, Bocchetta M, et al. Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc Natl Acad Sci U S A 2006;103:14128-33.
10. Rundell K, Parakati R. The role of the SV40 ST antigen in cell growth promotion and transformation. Semin Cancer Biol 2001;11:5-13.
11. Cacciotti P, Libener R, Betta P, et al. SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc Natl Acad Sci U S A 2001;98:12032-7.
12. Bocchetta M, Miele L, Pass HI, Carbone M. Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene 2003;22:81-9.
13. Fanning E, Knippers R. Structure and function of simian virus 40 large tumor antigen. Annu Rev Biochem 1992;61:55-85.
14. Pipas J, Levine A. Role of T antigen interactions with p53 in tumorigenesis. Semin Cancer Biol 2001;11:23-30.
15. Keller JM, Alwine JC. Activation of the SV40 late promoter: direct effects of T antigen in the absence of viral DNA replication. Cell 984;36:381-9.
16. Zuo F, Kraus RJ, Gulick T, Moore DD, Mertz JE. Direct modulation of simian virus 40 late gene expression by thyroid hormone and its receptor. J Virol 1997;71:427-36.
17. Zuo F, Mertz JE. Simian virus 40 late gene expression is regulated by members of the steroid/thyroid hormone receptor superfamily. Proc Natl Acad Sci U S A 1995;92:8586-90.
18. Wiley SR, Kraus RJ, Zuo F, Murray EE, Loritz K, Mertz JE. SV40 early-to-late switch involves titration of cellular transcriptional repressors. Genes Dev 1993;7:2206-19.
19. Okubo E, Lehman JM, Friedrich TD. Negative regulation ofmitotic promoting factor by the checkpoint kinase chk1 in simian virus 40 lytic infection. J Virol 2003;77:1257-67.
20. Gordon-Shaag A, Yosef Y, Abd El-Latif M, Oppenheim A. The abundant nuclear enzyme PARP participates in the life cycle of simian virus 40 and is stimulated by minor capsid protein VP3. J Virol 2003;77:4273-82.
21. Shivapurkar N, Wiethege T, Wistuba II, et al. Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J Cell Biochem 1999;76:181-8.
22. Galateau-Salle F, Bidet PH, Iwatsubo Y, et al. SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma, and non-malignant pulmonary diseases. J Pathol 1988;184:252-7.
23. Bocchetta M, Di Resta I, Powers A, et al. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci U S A 2000;97:10214-9.
24. Yu J, Boyapati A, Rundell K. Critical role for SV40 small-t antigen in human cell transformation. Virology 2001;290:192-8.
25. Yang H, Bocchetta M, Kroczynska B, et al. TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. Proc Natl Acad Sci U S A 2006;103:10397-402.
26. Pass HI, Vogelzang N, Hahn SM, Carbone M. Malignant pleural mesothelioma. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. Philadelphia: Lippincott Williams and Wilkins; 2005. p. 1687-715.
27. Cicala C, Pompetti F, Carbone M. SV40 induces mesotheliomas in hamsters. Am J Pathol 1993;142:1524-33.
28. Stratton K, Almario DA, McCormick M, editors. SV40 contamination of polio vaccine and cancer. IOM Report. In: Immunization safety review. Washington, DC: The National Academies Press; 2002. p. 19-84.
29. Klein G, Powers A, Croce C. Association of SV40 with human tumors. Oncogene 2002;21:1141-9.
30. Wong M, Pagano JS, Schiller JT, Tevethia SS, Raab-Traub N, Gruber J. New associations of human papillomavirus, Simian virus 40, and Epstein-Barr virus with human cancer. J Natl Cancer Inst 2002;94:1832-6.
31. Pagano JS, Blaser M, Buendia MA, et al. Infectious agents and cancer: criteria for a causal relation. Sem Cancer Biol 2004;14:453-71.
32. Carbone M, Albelda SM, Broaddus VC, et al. Eighth International Mesothelioma Interest Group. Oncogene 2007;26:6959-67.
33. Carbone M, Burck C, Rdzanek M, Rudzinski J, Cutrone R, Bocchetta M. Different susceptibility of human mesothelial cells to polyomavirus infection and malignant transformation. Cancer Res 2003;63:6125-9.
34. Fahrbach KM, Katzman RB, Rundell K. Role of SV40 ST antigen in the persistent infection of mesothelial cells. Virology 2008;370:255-63.
35. Foddis R, De Rienzo A, Broccoli D, et al. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 2002;21:1434-42.
36. Schilling LJ, Farnham PJ. Inappropriate transcription from the 5′ end of the murine dihydrofolate reductase gene masks transcriptional regulation. Nucleic Acids Res 1994;22:3061-8.
37. Nuovo GJ. Diagnosis of human papillomavirus using in situ hybridization and in situ polymerase chain reaction. In: Aquino de Muro M, Rapley R, editors. Methods in Molecular Biology: gene probes, principles and protocols. Totowa: Humana Press; 2002. p. 113-36.
38. Yajima T, Yagihashi A, Kameshima H, et al. Quantitative reverse transcription-PCR assay of the RNA component of human telomerase using the Taq-Man fluorogenic detection system. Clin Chem 1998;44:2441-5.
39. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 2005;435:682-6.
40. Gregory RI, Yan KP, Amuthan G, et al. The Microprocessor complex mediates the genesis of micro-RNAs. Nature 2004;432:235-40.
41. Tran N, Raponi M, Dawes IW, Arndt GM. Control of specific gene expression in mammalian cells by coexpression of long complementary RNAs. FEBS Lett 2004;573:127-34.
42. Billy E, Brondani V, Zhang H, Müller U, Filipowicz W. Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines. Proc Natl Acad Sci U S A 2001;98:14428-33.
43. Knight SW, Bass BL. A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans. Science 2001;293:2269-71.
44. Gromak N, West S, Proudfoot NJ. Pause sites promote transcriptional termination of mammalian RNA polymerase II. Mol Cell Biol 2006;26:3986-96.
45. ClemensMJ. PKR-a protein kinase regulated by double-stranded RNA. Int J Biochem Cell Biol 1997;29:945-9.
46. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:1096-100.
47. Sterman DH, Recio A, Carroll RG, et al. A Phase I clinical trial of single dose intrapleural IFN-β gene transfer for malignant mesothelioma and metastatic pleural effisions: high rate of antitumor immune responses. Cli Cancer Res 2007;13:4456-66.
48. Cole CN. Polyomaviruses. In: Fields BN, Knipe DM, Howley PM, editors. Fields Virology. Philadelphia: Lippincott-Raven Publishers;1996. p. 1997-2043.